APA (7th ed.) Citation

Dellinger, T., Lee, S., Sun, V., Ruel, N., Liu, X., Lin, W., . . . Han, E. (2019). Quality of life (QoL) in ovarian cancer patients following hyperthermic intraperitoneal chemotherapy (HIPEC) versus intraperitoneal (IP) chemotherapy. Gynecologic Oncology, 154, 214. https://doi.org/10.1016/j.ygyno.2019.04.496

Chicago Style (17th ed.) Citation

Dellinger, T., S.J Lee, V. Sun, N.H Ruel, X. Liu, W.C.M Lin, M. Kebria, and E.S Han. "Quality of Life (QoL) in Ovarian Cancer Patients Following Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus Intraperitoneal (IP) Chemotherapy." Gynecologic Oncology 154 (2019): 214. https://doi.org/10.1016/j.ygyno.2019.04.496.

MLA (9th ed.) Citation

Dellinger, T., et al. "Quality of Life (QoL) in Ovarian Cancer Patients Following Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus Intraperitoneal (IP) Chemotherapy." Gynecologic Oncology, vol. 154, 2019, p. 214, https://doi.org/10.1016/j.ygyno.2019.04.496.